| Revenue growth | 18% YoY growth in FY26; Q4 up 22% YoY. |
|---|---|
| Margins | Gross margin up 100bps to 7.5%; aiming for 5% EBITDA by FY30. |
| Demand visibility | Strong traction in Northeast (>50% growth) and North India (25-30%). |
| Management confidence | High; projecting ₹6000cr revenue and 5% EBITDA margin by FY30. |
Growth
FY26 revenue grew 18% to ₹1283cr; Q4 revenue rose 22% YoY to ₹356cr. Gross margins improved to 7.5% from 6.5%.
Outlook
Targeting ₹6000cr revenue by FY30. Planned capex of ₹234cr for 5.5 lakh sq ft additional warehouse capacity.
Risks
Capital-intensive hospital segment; market readiness for AI consulting services; transition disruption from branded to generic medicine sales.
Last quarter's promises, checked
Delivered
- Guided Q3FY26 GM 7.4% to 7.6% → delivered 7.5% (= BEAT)
- Guided Retailer Shakti EBITDA break-even Q4FY26 → delivered break-even (= BEAT)
- Guided 293 Healthbuddies count → delivered 293+ (= BEAT)
Partly delivered
- Guided 80,000 sq ft warehouse expansion → delivered partial capacity (= PARTIAL)
Missed
- Guided 30% YoY growth for FY26 → delivered 18% (= MISS)
Earnings Call filed with BSE, NSE: HEALTHX. Summary written with AI assistance from the document.
Health X Platform Ltd: key numbers
- Share price
- ₹288.65
- Market cap
- ₹918.2 Cr
- Revenue (annual)
- ₹1,319 Cr
- Net profit (annual)
- ₹1.18 Cr
- P/E (TTM)
- -45.5×Sector 57.8×
- Promoter holding
- 74.07%-0.77% QoQ
- FII holding
- 2.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Health X Platform Ltd
All →Health X Platform Other Announcement
Health X Platform Limited dispatched letters to shareholders with unregistered emails, providing web-links for the FY2025-26 Annual Report and 37th AGM notice.
Health X Platform Annual Report
Health X Platform Limited has filed its Annual Report for the financial year 2025-26. The company reported a consolidated total revenue of Rs. 1,319.27 Crore for the period.
Health X Platform Earnings Call Transcript: Key Takeaways
Health X is aggressively scaling its digital B2B and B2C pharmacy platforms, showing strong top-line momentum while burning cash on technology and geographical expansion.
- Call
- Guides 100% growth
Health X Platform Investor Presentation: Key Takeaways
Health X Platform reports strong Q1 FY27 growth with revenue at ₹440.3 Cr and 7.8% gross margins, leveraging its B2C SastaSundar and B2B Retailer Shakti ecosystems.
- Call
- Guides 30% growth
Health X Platform Q1 FY27 Results: Net Profit ₹2 Cr, Down 92.5% YoY
Health X Platform Ltd reported revenue from operations of ₹446.8 Cr (+49.7% YoY) and net profit of ₹2 Cr (-92.5% YoY) for Q1 FY27.
- Key figure
- Net profit ₹2 Cr · -92.5% YoY
Health X Platform Earnings Call: Key Takeaways
Health X Platform Ltd (formerly Sastasundar) announced a corporate restructuring to separate its Healthcare Services and Financial Services businesses into distinct listed entities to enhance focus and value.